Results 141 to 150 of about 5,346,158 (173)

Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]

open access: yesBlood Adv
Khalife-Hachem S   +15 more
europepmc   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm

Journal of the National Comprehensive Cancer Network, 2023
Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare hematologic malignancy with an aggressive clinical course and poor prognosis. BPDCN is most often characterized by its presentation with distinct cutaneous lesions. Bone marrow involvement, lymphadenopathy, splenomegaly, and/or cytopenias are also seen to varying degrees.
Akriti, Jain, Kendra, Sweet
openaire   +3 more sources

Home - About - Disclaimer - Privacy